Undifferentiated Pleomorphic Sarcoma
📧 Sign up to get email alerts when something new happens for Undifferentiated Pleomorphic Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating doxorubicin with upfront dexrazoxane for advanced or metastatic soft tissue sarcoma has completed enrollment with r…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma [Phase 2]
Phase II study update for 609A in advanced undifferentiated pleomorphic sarcoma is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of LY3435151 in Participants With Solid Tumors [Phase 1]
Phase 1 study of LY3435151 in solid tumors, including triple-negative breast cancer, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS [Phase 2]
Phase 2 trial update investigating carilizumab in combination with apatinib for unresectable undifferentiated pleomorphic sarcoma and alveol…
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating nivolumab with or without ipilimumab in metastatic or unresectable sarcoma shows results from a completed study.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma [Phase 2]
Phase 2 trial investigating anlotinib hydrochloride plus toripalimab in unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS…
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Alisertib in Treating Patients With Advanced or Metastatic Sarcoma [Phase 2]
A Phase 2 trial update of alisertib in patients with advanced or metastatic soft tissue sarcomas, including myxofibrosarcoma and several his…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) [Phase 1, Phase 2]
Phase 1/2 trial of gemcitabine and docetaxel with pazopanib for neoadjuvant treatment in soft tissue sarcoma was terminated; results posted …
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes [Phase 2]
A Phase 2 trial evaluated the combination of gemcitabine, docetaxel, and bevacizumab in selected sarcoma subtypes, including leiomyosarcoma …
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung [Phase 2]
Phase 2 study evaluating REOLYSIN (pelareorep) for bone and soft tissue sarcomas metastatic to the lung has been completed, assessing safety…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma [Phase 2]
Phase 2 clinical trial evaluating sorafenib for metastatic, locally advanced, or recurrent sarcoma has completed and posted results in 2014.
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma [Phase 2]
Phase II trial results for sunitinib malate in metastatic or surgically unresectable soft tissue sarcoma were posted, evaluating activity ac…